| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |